MCK McKesson Corporation

Healthcare · Medical Distribution

6 · Fair Momentum 7.0 · Neutral Watch 13y streak

853.71

-1.79%

About the company

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Website

0.44%

10.08%

3.76

99.5B

22.89

37.29

840.21

52-week range

854

low 673 high 999

Dividend deep dive

McKesson Corporation (MCK) is a Healthcare sector company specializing in Medical Distribution. The company currently offers a dividend yield of 0.39%. This yield is below its 5-year average of 0.59% and its 5-year historical low of 0.42%, indicating an "overvalued" status according to yield theory. McKesson has demonstrated a commitment to returning capital to shareholders, maintaining a consistent dividend increase streak. Its current market capitalization stands at $98.498 billion USD.

Dividend history

McKesson Corporation has a record of 13 consecutive years of dividend increases, qualifying it as a CCC 'contender.' Over the past three years, the dividend grew at a Compound Annual Growth Rate (CAGR) of 14.85%, while the five-year CAGR was 13.01%. Annual dividends per share have increased steadily: $0.96 in 2014, $1.04 in 2015, $1.12 in 2016, $1.24 in 2017, $1.46 in 2018, $1.60 in 2019, $1.66 in 2020, $1.78 in 2021, $2.02 in 2022, $2.32 in 2023, $2.66 in 2024, and projected $3.06 in 2025. Dividends are paid quarterly.

Dividend safety

McKesson's dividend appears well-covered with a low payout ratio of 8.55% based on its earnings per share of $38.36 USD. The company does not report FFO payout percentage, as it is not a REIT.

Quantic · Free

Read the rest of the safety verdict

Plus the key risks and what to watch next — free, no card.

Try a sample portfolio Sign up free

AI-generated from Quantic's dividend data · Updated 17 Jul 2026 · Information, not financial advice.